news 2021

« BACK

Pharmacology



Results 1 - 6 of 6.


Health - Pharmacology - 12.11.2021
Presentation of the first personalized virtual planning and navigation system for craniosynostosis surgery
Hospital Gregorio Marańón and Universidad Carlos III de Madrid (UC3M) have presented a navigation system that will improve planning, precision, and personalisation in surgical correction of craniosynostosis (a congenital defect causing cranial malformations). Developed by doctors and engineers from both institutions, it combines surgical navigation, three-dimensional photography, and augmented reality so that surgeons can estimate and correct the position of bone fragments during surgery.

Pharmacology - Life Sciences - 22.09.2021
ADHD and impulsivity: new potential targets to approach the treatment for neuropsychiatric disorders
ADHD and impulsivity: new potential targets to approach the treatment for neuropsychiatric disorders
A study published in the journal Pharmacological Research describes the existence of a complex built by dopamine and noradrenergic receptors that could be a therapeutic target of potential interest to tackle the attention deficit hyperactivity disorder (ADHD) and impulsivity. The paper, a preclinical study, has been carried out by the Research Group on Molecular Neuropharmacology, under the supervision of the lecturer Vicent Casadó, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona ( IBUB ).

Health - Pharmacology - 14.09.2021
New pathway of the energy metabolism in peripheral tissues regulated by cytokine GDF15
New pathway of the energy metabolism in peripheral tissues regulated by cytokine GDF15
A study published in the journal Cell Reports describes a new pathway related to the activity of receptors that are associated with several metabolic or cardiovascular diseases such as diabetes, obesity and hypertension. According to the conclusions, many antidiabetic effects of the activators of the PPAR?/- receptors -potential therapeutic targets for the treatment of type 2 diabetes- are regulated by cytokine GDF15, a protein expressed under conditions of physiological stress.

Pharmacology - Health - 09.09.2021
Light-activated drugs: localized medicine without side effects
Light-activated drugs: localized medicine without side effects
Photopharmacology is an emerging area of science based on the development of photosensitive drugs, that is, drugs that activate with light. A team from IDIBELL and the University of Barcelona has worked on two treatments based on this innovative technology: a morphine derivative that does not create addiction and a new treatment against psoriasis.

Pharmacology - Life Sciences - 19.05.2021
Development of a peptide that allows cannabis-derived drugs to relieve pain without side effects
Scientists from the Proteomics and Protein Chemistry Research Group and the Neuropharmacology-Neurophar Laboratory have developed a peptide which is an ideal candidate for reducing the cognitive side effects of pain treatment with cannabis derivatives. An international team, led by researchers from UPF David Andreu and Rafael Maldonado , has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa , to fight pain in mice without side effects.

Health - Pharmacology - 03.03.2021
Administering zinc to covid-19 patients could help towards their recovery
Administering zinc supplements to covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering the worst effects of the disease. These are the findings of a study by physicians and researchers from the Hospital del Mar, Hospital del Mar Medical Research Institute and UPF.